Christoph K. Naber Appointed Stent for Life Initiative Chairman / Stent Save a Life Chairman
Christoph Kurt Naber, Germany
Director, Department of Cardiology and Angiology, Contilia
Heart and Vascular Center Elisabeth-Krankenhaus, Essen
During the seven years of Stent for Life Initiative’s existence, the SFL Mission has remained the same:
Reduce the mortality and morbidity of patients suffering from acute coronary syndromes (ACS) by supporting the implementation of European Clinical Practice Guidelines on Myocardial Revascularization at national and regional levels.
We have accomplished a lot – today patients from 21 countries in Europe, Asia, Africa and South America benefit from SFL programs. In partnership with hospitals, payers, governments and industry partners, SFL helps to create healthcare models that can deliver more efficient and improved care to ACS patients while maintaining or reducing costs.
We are pleased to announce that Dr. Christoph K. Naber has been appointed Stent for Life Initiative Chairman for the years 2016 – 2018. Dr. Naber is an active member of the PCR family. He is the course-co-director of EuroPCR and PCR London Valves, and course-director of AsiaPCR. He has served as a member of the executive board of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology (ESC), and is a member of the editorial boards of EuroIntervention and AsiaIntervention. Dr. Christoph Naber is a past-chairman of the German Working Group of Interventional Cardiology (AGIK/DGK).
We are very proud that the SFL activities’ impact on healthcare can be validated by clinical and economic evidence. To measure the SFL’s impact on STEMI patients’ access to PPCI, the third in a row Stent for Life ACS market survey will be initiated this year under the leadership of Christoph K. Naber. The ESC member and affiliate member countries will be invited to collect data on reperfusion treatment by using a self-administered questionnaire, and provide descriptive analysis of the type of reperfusion utilization, time delays, pharmacotherapy and medical device use at a national level.
Join us in wishing Christoph K. Naber all the best and much success in leading the Stent for Life Initiative!